5 Key Takeaways

• 1

  Atropine drop therapy is a key option in myopia management, effective for visual improvement and disease-risk mitigation.

• 2

  Low-dose atropine, particularly at 0.05%, has shown efficacy with minimal side effects, making it a preferred choice for treatment.

• 3

  The prescribed dosage of atropine should be patient-driven and adjustable based on progression or side effects.

• 4

  Atropine should be administered once nightly, and children must be monitored for visual discomfort during the day.

• 5

  Currently, there are no FDA-approved low-dose atropine drops in the U.S., necessitating local compounding or mail-order.